Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19, 2022, Charnley et al
Discussion in 'Long Covid research' started by Andy, Jun 13, 2022.
Discussion in 'Long Covid research' started by Andy, Jun 13, 2022.